Medical Condition News

RSS

Studies reveal new benefits of Peptan in preventing osteoporosis

Studies Conducted at INRA-Agroparistech Laboratory Under Pr. Daniel Tome's Supervision and Published in November 2009, in the Official Journal of the International Bone and Mineral Society "Bone", Reveal new Benefits for Peptan(TM) in Osteoporosis Prevention

16 Dec 2009

Cancer Research UK's phase I trial results of CHT25 published in Clinical Cancer Research

TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research, today (Tuesday).

16 Dec 2009

Deaths from heart disease peak in December and January, US database reveals

'Tis the season… for a heart attack? According to Dr. Keith Churchwell, associate director of the Vanderbilt Heart and Vascular Institute at Vanderbilt University Medical Center, a US database of 53 million deaths occurring between 1973 and 2001 reveals that deaths from heart disease peak in December and January, with spikes on Christmas and New Year's Day.

16 Dec 2009

Pharmacy directors willing to cover tanezumab at lower prices

HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.

16 Dec 2009

Challenges U.S. and U.K. cancer patients face in gaining access to expensive treatments

Cancer patients in both the United States and the United Kingdom face challenges in gaining access to expensive treatments, according to research published in the December issue of The Milbank Quarterly.

16 Dec 2009

Spiritual care can improve outcomes in terminally ill cancer patients

In a new study of terminally ill cancer patients, researchers at Dana-Farber Cancer Institute found support of patients' spiritual needs by the medical team is associated with greater use of hospice, less aggressive care, and greater quality of life near death. The

16 Dec 2009

Modulating PN aggregase pathway may offer hope for Alzheimer’s disease

Proteostasis Therapeutics announced today that modulating a key Proteostasis Network (PN) pathway may offer a novel approach to Alzheimer’s disease, a finding that was published in the journal Cell by its scientific founders Andrew Dillin, Ph.D., and Jeffery Kelly, Ph.D. The publication describes how regulation of an aggregase pathway reduced the neurodegenerative effects of beta amyloid aggregates that are a hallmark of the disease.

16 Dec 2009

VA and Department of Defense clinical practice guidelines for mTBI

The current issue of the Department of Veterans Affairs (VA's) Journal of Rehabilitation Research and Development (JRRD) features 19 timely scientific articles on traumatic brain injury (TBI), based on work by VA researchers and colleagues from a variety of disciplines. The papers were commissioned for a "state of the art" conference VA held last year to advance research in this area.

16 Dec 2009

EDP Biotech develops a simple blood test for detecting early-stage colon cancer

Medical researchers with EDP Biotech Corporation (EDP) have captured national attention with their revolutionary new technology for a simple blood test to detect early-stage colon cancer.

16 Dec 2009

Englerin A possesses high toxicity for kidney cancer cells, researchers discover

Englerin A, a natural product recently discovered in an African plant, possesses high toxicity for kidney cancer cells but low toxicity for other cells. Therefore this compound is potentially qualified for further evaluation toward an application in cancer therapy.

16 Dec 2009

ThromboGenics completes enrollment in second microplasmin Phase III trial

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the second Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.

16 Dec 2009

Celebrities unveil Race for Life 2010 t-shirts to raise money for Cancer Research UK

A TRIO of celebrities including choreographer, Arlene Phillips; girlfriend of Arsenal star Theo Walcott, Melanie Slade; and fashion designer Tracey Boyd, have given the classic white tee a fun twist with a splash of colour as their new collection of Race for Life 2010 t-shirts is unveiled to raise money for Cancer Research UK.

16 Dec 2009

Preclinical study of Arno Therapeutics' drug candidate AR-42 presented at ASH 2009

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the presentation of a poster at the annual American Society of Hematology (ASH) meeting that describes the preclinical activity of Arno’s drug candidate AR-42 against leukemia stem cells (LSCs).

16 Dec 2009

NEI study reports 66.4 percent increase in myopia in Americans

According to the American Academy of Ophthalmology, the 66.4 percent increase in myopia in Americans since the 1970s, as reported in the recent National Eye Institute (NEI) study, is significant and will impact healthcare costs as well as vision quality.

16 Dec 2009

Physicians need to utilize best practices to treat HAE patients in emergency settings

Hereditary Angioedema (HAE) is an autosomal dominant disease causing acute attacks of intense edema. These attacks can result in life-threatening complications, including asphyxiation.

16 Dec 2009

Nitric oxide opens up new treatment option for septic shock

Scientists at VIB and Ghent University in Flanders, Belgium have found an unexpected ally for the treatment of septic shock, the major cause of death in intensive care units.

16 Dec 2009

New top-line results for patient preference study evaluating Kristalose for Oral Solution announced

Cumberland Pharmaceuticals Inc. (CPIX) today announced new top-line results for a patient preference study evaluating Kristalose (lactulose) for Oral Solution, a prescription laxative packaged as a crystalline powder, compared to similar products in liquid forms.

16 Dec 2009

Higher leptin levels associated with lower incidence of AD and dementia

Persons with higher levels of leptin, a protein hormone produced by fat cells and involved in the regulation of appetite, may have an associated reduced incidence of Alzheimer disease and dementia, according to a study in the December 16 issue of JAMA.

16 Dec 2009

Study suggests physical activity influences depression and fatigue by increasing self-efficacy

Physical activity is known to reduce depression and fatigue in people struggling with chronic illness. A new study indicates that this effect stems from an individual's sense of mastery over - or belief in his or her ability to achieve - certain physical goals.

16 Dec 2009

Discovery may yield new treatments for hormone-resistant prostate cancer

Patients with advanced prostate cancer are often treated with hormones, but when the tumours start growing again they have more and different blood vessels, reveals a thesis from the Sahlgrenska Academy, at the University of Gothenburg, Sweden. This discovery paves the way for new treatments for hormone-resistant prostate cancer.

16 Dec 2009

Medical Condition News

Studies reveal new benefits of Peptan in preventing osteoporosis

Cancer Research UK's phase I trial results of CHT25 published in Clinical Cancer Research

Deaths from heart disease peak in December and January, US database reveals

Pharmacy directors willing to cover tanezumab at lower prices

Challenges U.S. and U.K. cancer patients face in gaining access to expensive treatments

Spiritual care can improve outcomes in terminally ill cancer patients

Modulating PN aggregase pathway may offer hope for Alzheimer’s disease

VA and Department of Defense clinical practice guidelines for mTBI

EDP Biotech develops a simple blood test for detecting early-stage colon cancer

Englerin A possesses high toxicity for kidney cancer cells, researchers discover

ThromboGenics completes enrollment in second microplasmin Phase III trial

Celebrities unveil Race for Life 2010 t-shirts to raise money for Cancer Research UK

Preclinical study of Arno Therapeutics' drug candidate AR-42 presented at ASH 2009

NEI study reports 66.4 percent increase in myopia in Americans

Physicians need to utilize best practices to treat HAE patients in emergency settings

Nitric oxide opens up new treatment option for septic shock

New top-line results for patient preference study evaluating Kristalose for Oral Solution announced

Higher leptin levels associated with lower incidence of AD and dementia

Study suggests physical activity influences depression and fatigue by increasing self-efficacy

Discovery may yield new treatments for hormone-resistant prostate cancer

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News